AperçuGraphiqueProfilStatistiques clésDonnées financièresActualités
Dérivés
TraderScreen

BIOMERIEUX/  FR0013280286  /

Vienna Global Market
08/11/2024  15:30:19 Chg. +0.80 Volume Bid17:30:00 Demandez à17:30:00 Capitalisation boursière Dividende Y. Rapport P/E
101.60EUR +0.79% 0
Chiffrre d'affaires: -		 -Bid taille: - -Ask la taille: - 12.11 Mrd.EUR 0.83% 33.76
GlobeNewswire 20/06 AUROBAC THERAPEUTICS APPOINTS SCIENTIFIC ADVISORY BOARD
GlobeNewswire 03/06 AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in P...
GlobeNewswire 15/05 Transgene’s Combined General Meeting of May 15, 2024
GlobeNewswire 29/04 OpGen Provides Update on Business Operations and Strategic Opportunities
GlobeNewswire 25/04 UIICore unveiling / ECCMID announcement Analyst Targets
GlobeNewswire 18/04 deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing...
GlobeNewswire 04/12/2023 Oxford Biomedica signs agreement to acquire ABL Europe from Institut Mérieux, consolidating position...
GlobeNewswire 27/10/2023 USDA Appoints New Members to Food Safety Advisory Committee
GlobeNewswire 20/09/2023 Oxford Biomedica and Institut Mérieux enter into exclusive negotiations with respect to the proposed...
GlobeNewswire 19/10/2021 USDA Appoints New Members to Food Safety Advisory Committee
GlobeNewswire 05/10/2021 Quotient Limited Announces Appointment of Chief Commercial Officer
GlobeNewswire 04/10/2021 Quotient Limited Announces Appointment of New Chief Scientific & Medical Officer
GlobeNewswire 16/09/2021 Inventiva announces major recruitments to accelerate the development of lanifibranor in NASH
GlobeNewswire 01/06/2021 Quotient Limited Provides Fourth Quarter and Full Year Fiscal 2021 Results and provides Business Upd...
GlobeNewswire 10/03/2021 Oncorus Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
GlobeNewswire 23/02/2021 Quotient Limited Announces Manuel Mendez as Chief Executive Officer
GlobeNewswire 04/02/2021 Berkeley Lights Announces CFO Transition and C-Level Additions
GlobeNewswire 04/01/2021 Oncorus to Build GMP Viral Immunotherapy Clinical Manufacturing Facility in Andover, Mass.
GlobeNewswire 16/12/2020 MeMed Appoints Industry Veteran Chris Hibberd to its Board of Directors
GlobeNewswire 07/12/2020 Oncorus Appoints Steve Harbin as Chief Operating Officer and Chief of Staff
GlobeNewswire 29/09/2020 Synairgen plc - Interim results for the six months ended 30 June 2020
GlobeNewswire 17/09/2020 Victory Square Provides Corporate Update on the Strong Performance of Portfolio Companies
GlobeNewswire 15/07/2020 DNV3837 antibiotic candidate: the Phase II trial continues in the US
GlobeNewswire 15/06/2020 T2 Biosystems Announces Changes to Board of Directors
GlobeNewswire 04/05/2020 Alexis RIDEAU appointed Chief Executive Officer of DEINOVE with the ambition to strengthen the Comp...